come and predictors of gefitinib antitumor activity in East Asian chemonaive patients patients of Asian origin with re-fractory advanced non-small cell lung cancer: subset analysis
activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer. Cancer : Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung
predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced . Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status
cisplatin in patients with advanced, previously untreated non-small cell lung cancer LY900003 in patients with advanced non-small cell lung cancer who have not received prior
Cell Lung Cancer: Application to Cytological Specimens of Malignant Pleural Effusion and important advance in the treatment of non-small cell lung cancer (NSCLC). Recent pivotal trials
Molecular Targeted Drug among Non-Small Lung Cancer Patients under National Health Insurance , have been proven to provide clinical benefit to end-stage non-small cell lung cancer (NSCLC
為了持續優化網站功能與使用者體驗,本網站將Cookies分析技術用於網站營運、分析和個人化服務之目的。
若您繼續瀏覽本網站,即表示您同意本網站使用Cookies。